Twitter timeline

Oncodesign reports positive results for its MNK1/2 program

December 5, 2017

  • MNK1 and MNK2 are kinases targeted in a major activation pathway for several cancers
  • The program has identified highly targeted inhibitor molecules and produced promising cellular results paving the way for lead optimization to begin

Download